Unknown

Dataset Information

Low-Dose Alteplase During Primary Percutaneous Coronary Intervention According to Ischemic Time.


ABSTRACT:

Background

Microvascular obstruction affects one-half of patients with ST-segment elevation myocardial infarction and confers an adverse prognosis.

Objectives

This study aimed to determine whether the efficacy and safety of a therapeutic strategy involving low-dose intracoronary alteplase infused early after coronary reperfusion associates with ischemic time.

Methods

This study was conducted in a prospective, multicenter, parallel group, 1:1:1 randomized, dose-ranging trial in patients undergoing primary percutaneous coronary intervention. Ischemic time, defined as the time from symptom onset to coronary reperfusion, was a pre-specified subgroup of interest. Between March 17, 2016, and December 21, 2017, 440 patients, presenting with ST-segment elevation myocardial in

SUBMITTER: McCartney PJ 

PROVIDER: S-EPMC7109518 | biostudies-literature | 2020 Mar

REPOSITORIES: biostudies-literature